Latest Posts › DE Supreme Court

Share:

Caremark Round II: Beware Red Flags in Drug Development

On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims...more

The Caremark Chimera: Can Directors Be Liable when the Red Flag is hidden from Them?

On June 18, 2019, in Marchand v. Barnhill, the Delaware Supreme Court revived a stockholder derivative lawsuit against the directors of ice-cream manufacturer Blue Bell Creameries USA, Inc. The suit alleged breaches of the...more

Delaware Supreme Court Affirms Merger Termination After Target Suffers Material Adverse Effect

Goodwin’s recent client alert – “A First: Delaware Court of Chancery Holds that Merger Target Suffered Material Adverse Effect” – discussed the Court of Chancery’s finding, in Akorn Inc. v. Fresenius Kabi AG, et al., that a...more

Delaware Supreme Court Clarifies The Role Of Deal Price In Appraisal Proceedings

In a long-awaited decision regarding Delaware’s appraisal statute, the Delaware Supreme Court ruled that in determining the fair value of a company, there is no presumption that the agreed upon transaction price is the fair...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide